Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Prepaid Assets (2021 - 2025)

Historic Prepaid Assets for Neuphoria Therapeutics (NEUP) over the last 3 years, with Q4 2025 value amounting to $713239.0.

  • Neuphoria Therapeutics' Prepaid Assets rose 6199.08% to $713239.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $713239.0, marking a year-over-year increase of 6199.08%. This contributed to the annual value of $740193.0 for FY2025, which is N/A changed from last year.
  • Neuphoria Therapeutics' Prepaid Assets amounted to $713239.0 in Q4 2025, which was up 6199.08% from $222319.0 recorded in Q3 2025.
  • Neuphoria Therapeutics' 5-year Prepaid Assets high stood at $2.3 million for Q4 2021, and its period low was $20897.0 during Q1 2025.
  • For the 3-year period, Neuphoria Therapeutics' Prepaid Assets averaged around $663516.7, with its median value being $440296.0 (2024).
  • Examining YoY changes over the last 5 years, Neuphoria Therapeutics' Prepaid Assets showed a top increase of 6199.08% in 2025 and a maximum decrease of 380.3% in 2025.
  • Quarter analysis of 3 years shows Neuphoria Therapeutics' Prepaid Assets stood at $2.3 million in 2021, then crashed by 80.66% to $440296.0 in 2024, then skyrocketed by 61.99% to $713239.0 in 2025.
  • Its Prepaid Assets stands at $713239.0 for Q4 2025, versus $222319.0 for Q3 2025 and $740193.0 for Q2 2025.